CoChat

Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment

Open access
Strikwerda-Brown, Cherie, Hobbs, Diana A., Gonneaud, Julie, St-Onge, Frédéric, Binette, Alexa Pichet, Ozlen, Hazal, Provost, Karine, Soucy, Jean-Paul, Buckley, Rachel F., Benzinger, Tammie L. S., Morris, John C., Villemagne, Victor L., Doré, Vincent, Sperling, Reisa A., Johnson, Keith A., Rowe, Christopher C., Gordon, Brian A., Poirier, Judes, Breitner, John C. S., Villeneuve, Sylvia, PREVENT-AD, HABS, and AIBL Research Groups, Tam, Angela, Labonte, Anne, Pichet Binette, Alexa, Faubert, Anne-Marie, Mathieu, Axel, Madjar, Cecile, Carrier, Charles Edouard, Dansereau, Christian, Kazazian, Christina, Lepage, Claude, Picard, Cynthia, Maillet, David, Michaud, Diane, Couture, Doris, Dea, Doris, Cuello, Claudio, Barkun, Alan, Evans, Alan, Courcot, Blandine, Tardif, Christine, Debacker, Clement, Jack, Clifford, Fontaine, David, Knopman, David, Multhaup, Gerhard, Near, Jamie, Leoutsakos, Jeannie-Marie, Maltais, Jean-Robert, Brandt, Jason, Pruessner, Jens, Morris, John, Breitner, John, Poirier, Judes, Cheewakriengkrai, Laksanun, Münter, Lisa-Marie, Collins, Louis, Chakravarty, Mallar, Sager, Mark, Dauar-Tedeschi, Marina, Eisenberg, Mark, Rajah, Natasha, Aisen, Paul, Toussaint, Paule-Joanne, Rosa-Neto, Pedro, Bellec, Pierre, Kostopoulos, Penelope, Etienne, Pierre, Tariot, Pierre, Orban, Pierre, Sperling, Reisa, Hoge, Rick, Thomas, Ronald, Gauthier, Serge, Craft, Suzanne, Villeneuve, Sylvia, Montine, Thomas, Nair, Vasavan, Bohbot, Veronique, Venugopalan, Vinod, Fonov, Vladimir, Ituria-Medina, Yasser, Khachaturian, Zaven, Teigner, Eduard, Anthal, Elena, Yu, Elsa, Ferdinand, Fabiola, Pogossova, Galina, Mayrand, Ginette, Duclair, Guerda, Gagne, Guylaine, Newbold-Fox, Holly, Leppert, Illana, Vallee, Isabelle, Vogel, Jacob, Tremblay-Mercier, Jennifer, Frenette, Joanne, Frappier, Josee, Kat, Justin, Miron, Justin, Wan, Karen, Mahar, Laura, Carmo, Leopoldina, Theroux, Louise, Dadar, Mahsa, Dufour, Marianne, Lafaille-Magnan, Marie-Elyse, Appleby, Melissa, Savard, Melissa, Tuwaig, Miranda, Petkova, Mirela, Rioux, Pierre, Meyer, Pierre-François, El-Khoury, Rana, Gordon, Renee, Giles, Renuka, Das, Samir, Wang, Seqian, Tabrizi, Shirin, Mathotaarachchi, Sulantha, Dubuc, Sylvie, Lee, Tanya, Beaudry, Thomas, Gervais, Valerie, Page, Veronique, Gonneaud, Julie, Ayranci, Gülebru, Pascoal, Tharick, Desautels, Rene, Benbouhoud, Fatiha, Saint-Fort, Eunice Farah, Verfaillie, Sander, Farzin, Sarah, Salaciak, Alyssa, Tullo, Stephanie, Vachon-Presseau, Etienne, Daoust, Leslie-Ann, Kobe, Theresa, Spreng, Nathan, McSweeney, Melissa, Nilsson, Nathalie, Pishnamazi, Morteza, Bedetti, Christophe, Hudon, Louise, Greco, Claudia, Chapleau, Marianne, St-Onge, Frederic, Boutin, Sophie, Geddes, Maiya, Ducharme, Simon, Jean, Gabriel, Sylvain, Elisabeth, Élie, Marie-Josee, Leblond-Baccichet, Gloria, Soucy, Jean-Paul, Ozlen, Hazal, Bailly, Julie, Mohammediyan, Bery, Chen, Yalin, Remz, Jordana, Johnson, Keith, Rentz, Dorene, Amariglio, Rebecca E., Blacker, Deborah, Buckley, Rachel, Chhatwal, Jasmeer P., Dickerson, Brad, Donovan, Nancy, Farrell, Michelle, Gagliardi, Geoffroy, Gatchel, Jennifer, Guzman-Velez, Edmarie, Jacobs, Heidi, Jutten, Roos, Lois Gomez, Cristina, Marshall, Gad, Oaoo, Kate, Pardilla-Delgado, Enmanuelle, Price, Julie, Prokopiou, Prokopis, Quiroz, Yakeel, Reynolds, Gretchen, Schultz, Aaron, Schultz, Stephanie, Sepulcre, Jorge, Skylar-Scott, Irina, Vannini, Patrizia, Vila-Castelar, Clara, Yang, Hyun-Sik, Masters, Colin L, Ward, Larry, Maruff, Paul, Fowler, Christopher, Martins, Ralph, Rainy-Smith, Stephanie, Taddei, Kevin, Brown, Belinda, Laws, Simon, Fripp, Jurgen, Bourgeat, Pierrick · 2022 · JAMA Neurology
Cited by 127

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Importance: National Institute on Aging–Alzheimer’s Association (NIA-AA) workgroups have proposed biological research criteria intended to identify individuals with preclinical Alzheimer disease (AD). Objective: To assess the clinical value of these biological criteria to identify older individuals without cognitive impairment who are at near-term risk of developing symptomatic AD. Design, Setting, and Participants: This longitudinal cohort study used data from 4 independent population-based cohorts (PREVENT-AD, HABS, AIBL, and Knight ADRC) collected between 2003 and 2021. Participants were older adults without cognitive impairment with 1 year or more of clinical observation after amyloid β and tau positron emission tomography (PET). Median clinical follow-up after PET ranged from 1.94 to 3.66 years. Exposures: Based on binary assessment of global amyloid burden (A) and a composite temporal region of tau PET uptake (T), participants were stratified into 4 groups (A+T+, A+T−, A−T+, A−T−). Presence (+) or absence (−) of neurodegeneration (N) was assessed using temporal cortical thickness. Main Outcomes and Measures: Each cohort was analyzed separately. Primary outcome was clinical progression to mild cognitive impairment (MCI), identified by a Clinical Dementia Rating score of 0.5 or greater in Knight ADRC and by consensus committee review in the other cohorts. Clinical raters were blind to imaging, genetic, and fluid biomarker data. A secondary outcome was cognitive decline, based on a slope greater than 1.5 SD below the mean of an independent subsample of individuals without cognitive impairment. Outcomes were compared across the biomarker groups. Results: Among 580 participants (PREVENT-AD, 128; HABS, 153; AIBL, 48; Knight ADRC, 251), mean (SD) age ranged from 67 (5) to 76 (6) years across cohorts, with between 55% (137/251) and 74% (95/128) female participants. Across cohorts, 33% to 83% of A+T+ participants progressed to MCI during follow-up (mean progression time, 2-2.72 years), compared with less than 20% of participants in other biomarker groups. Progression further increased to 43% to 100% when restricted to A+T+(N+) individuals. Cox proportional hazard ratios for progression to MCI in the A+T+ group vs other biomarker groups were all 5 or greater. Many A+T+ nonprogressors also showed longitudinal cognitive decline, while cognitive trajectories in other groups remained predominantly stable. Conclusions and Relevance: The clinical prognostic value of NIA-AA research criteria was confirmed in 4 independent cohorts, with most A+T+(N+) older individuals without cognitive impairment developing AD symptoms within 2 to 3 years.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamaneurol.2022.2379

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 127

Metadata

Authors
Strikwerda-Brown, C., Hobbs, D. A., Gonneaud, J., St-Onge, F., Binette, A. P., Ozlen, H., Provost, K., Soucy, J.-P., Buckley, R. F., Benzinger, T. L. S., Morris, J. C., Villemagne, V. L., Doré, V., Sperling, R. A., Johnson, K. A., Rowe, C. C., Gordon, B. A., Poirier, J., Breitner, J. C. S., Villeneuve, S., PREVENT-AD, H., Tam, A., Labonte, A., Pichet Binette, A., Faubert, A.-M., Mathieu, A., Madjar, C., Carrier, C. E., Dansereau, C., Kazazian, C., Lepage, C., Picard, C., Maillet, D., Michaud, D., Couture, D., Dea, D., Cuello, C., Barkun, A., Evans, A., Courcot, B., Tardif, C., Debacker, C., Jack, C., Fontaine, D., Knopman, D., Multhaup, G., Near, J., Leoutsakos, J.-M., Maltais, J.-R., Brandt, J., Pruessner, J., Morris, J., Breitner, J., Poirier, J., Cheewakriengkrai, L., Münter, L.-M., Collins, L., Chakravarty, M., Sager, M., Dauar-Tedeschi, M., Eisenberg, M., Rajah, N., Aisen, P., Toussaint, P.-J., Rosa-Neto, P., Bellec, P., Kostopoulos, P., Etienne, P., Tariot, P., Orban, P., Sperling, R., Hoge, R., Thomas, R., Gauthier, S., Craft, S., Villeneuve, S., Montine, T., Nair, V., Bohbot, V., Venugopalan, V., Fonov, V., Ituria-Medina, Y., Khachaturian, Z., Teigner, E., Anthal, E., Yu, E., Ferdinand, F., Pogossova, G., Mayrand, G., Duclair, G., Gagne, G., Newbold-Fox, H., Leppert, I., Vallee, I., Vogel, J., Tremblay-Mercier, J., Frenette, J., Frappier, J., Kat, J., Miron, J., Wan, K., Mahar, L., Carmo, L., Theroux, L., Dadar, M., Dufour, M., Lafaille-Magnan, M.-E., Appleby, M., Savard, M., Tuwaig, M., Petkova, M., Rioux, P., Meyer, P.-F., El-Khoury, R., Gordon, R., Giles, R., Das, S., Wang, S., Tabrizi, S., Mathotaarachchi, S., Dubuc, S., Lee, T., Beaudry, T., Gervais, V., Page, V., Gonneaud, J., Ayranci, G., Pascoal, T., Desautels, R., Benbouhoud, F., Saint-Fort, E. F., Verfaillie, S., Farzin, S., Salaciak, A., Tullo, S., Vachon-Presseau, E., Daoust, L.-A., Kobe, T., Spreng, N., McSweeney, M., Nilsson, N., Pishnamazi, M., Bedetti, C., Hudon, L., Greco, C., Chapleau, M., St-Onge, F., Boutin, S., Geddes, M., Ducharme, S., Jean, G., Sylvain, E., Élie, M.-J., Leblond-Baccichet, G., Soucy, J.-P., Ozlen, H., Bailly, J., Mohammediyan, B., Chen, Y., Remz, J., Johnson, K., Rentz, D., Amariglio, R. E., Blacker, D., Buckley, R., Chhatwal, J. P., Dickerson, B., Donovan, N., Farrell, M., Gagliardi, G., Gatchel, J., Guzman-Velez, E., Jacobs, H., Jutten, R., Lois Gomez, C., Marshall, G., Oaoo, K., Pardilla-Delgado, E., Price, J., Prokopiou, P., Quiroz, Y., Reynolds, G., Schultz, A., Schultz, S., Sepulcre, J., Skylar-Scott, I., Vannini, P., Vila-Castelar, C., Yang, H.-S., Masters, C. L., Ward, L., Maruff, P., Fowler, C., Martins, R., Rainy-Smith, S., Taddei, K., Brown, B., Laws, S., Fripp, J., & Bourgeat, P.
Venue
JAMA Neurology
Published
2022-10-01
Volume
79
Issue
10
Pages
975
ISSN
2168-6149 (ISSN-L)
OpenAlex
W4288843991
Cited by
127
References
16
FWCI
15.71
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.